Early Clinical Response is Associated With a Decreased Risk of Recurrent <i>Pseudomonas aeruginosa</i> Ventilator-Associated Pneumonia
This study found that early clinical response and improvement in PaO<sub>2</sub>/FiO<sub>2</sub> were associated with a decreased risk of PA-VAP recurrence. Individualized treatment durations based on clinical response may allow clinicians to safely utilize shorter antibiotic courses for PA-VAP.
Authors
- Ryan Gumbleton
- Marco R. Scipione (ORCID: https://orcid.org/0000-0001-5242-3847)
- Jing Zhao (ORCID: https://orcid.org/0000-0001-8973-0429)
- Andrew Huang
Institutions
- Harper University Hospital (US)
- Detroit Receiving Hospital (US)
- Children's Hospital of Michigan (US)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1177/10600280251355630
- Primary Topic
- Nosocomial Infections in ICU
- Type
- article
- Field-Weighted Citation Impact
- 0.00